P3 Health Partners (NASDAQ:PIII) Now Covered by Lake Street Capital

Key Points

• Lake Street Capital has reiterated a "buy" rating for P3 Health Partners (PIII), with a price target of $20.00, indicating a potential upside of 154.78% from the current price.
• P3 Health Partners reported a quarterly loss of ($6.23) EPS, falling short of analyst expectations, and had a revenue of $355.79 million for the quarter.
• Institutional investors have shown increasing interest in P3 Health Partners, with significant stake acquisitions, including a 77.3% increase by Abundance Wealth Counselors in the first quarter.

Lake Street Capital initiated coverage on shares of P3 Health Partners (NASDAQ:PIII - Free Report) in a report released on Thursday morning, MarketBeat reports. The firm issued a buy rating and a $20.00 price objective on the stock.

P3 Health Partners Stock Performance

Shares of P3 Health Partners stock traded down $0.01 during trading on Thursday, reaching $8.33. The company's stock had a trading volume of 1,320 shares, compared to its average volume of 24,177. The company has a 50-day moving average price of $6.87 and a two-hundred day moving average price of $7.91. The firm has a market cap of $59.86 million, a PE ratio of -0.18 and a beta of 0.82. P3 Health Partners has a fifty-two week low of $5.80 and a fifty-two week high of $29.19. The company has a current ratio of 0.31, a quick ratio of 0.31 and a debt-to-equity ratio of 2.29.

P3 Health Partners (NASDAQ:PIII - Get Free Report) last announced its quarterly earnings data on Thursday, August 14th. The company reported ($6.23) earnings per share (EPS) for the quarter, missing the consensus estimate of ($3.29) by ($2.94). The firm had revenue of $355.79 million during the quarter, compared to analyst estimates of $356.52 million. P3 Health Partners had a negative net margin of 9.99% and a negative return on equity of 183.60%. P3 Health Partners has set its FY 2025 guidance at EPS. On average, analysts forecast that P3 Health Partners will post -0.67 EPS for the current year.

Hedge Funds Weigh In On P3 Health Partners

Several institutional investors have recently bought and sold shares of the company. Trinity Financial Advisors LLC increased its stake in P3 Health Partners by 22.5% in the 1st quarter. Trinity Financial Advisors LLC now owns 1,278,037 shares of the company's stock valued at $222,000 after buying an additional 234,500 shares during the period. Abundance Wealth Counselors increased its stake in P3 Health Partners by 77.3% in the 1st quarter. Abundance Wealth Counselors now owns 400,000 shares of the company's stock valued at $66,000 after buying an additional 174,395 shares during the period. Wealthedge Investment Advisors LLC acquired a new position in P3 Health Partners in the 4th quarter valued at $83,000. XTX Topco Ltd acquired a new position in P3 Health Partners in the 4th quarter valued at $46,000. Finally, Cresset Asset Management LLC increased its stake in P3 Health Partners by 33.3% in the 1st quarter. Cresset Asset Management LLC now owns 200,000 shares of the company's stock valued at $33,000 after buying an additional 50,000 shares during the period. 7.75% of the stock is owned by institutional investors and hedge funds.

P3 Health Partners Company Profile

P3 Health Partners Inc, a patient-centered and physician-led population health management company, provides superior care services in the United States. It operates clinics and wellness centers. P3 Health Partners Inc was founded in 2020 and is based in Henderson, Nevada.